AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Lite Strategy, Inc. Director's Dealing 2018

Feb 26, 2018

34267_dirs_2018-02-26_032a61c8-dae9-4c06-b5cd-d6d3b5aa8c63.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2018-02-22

Reporting Person: DRISCOLL FREDERICK W (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct